HOME
SERVICES
INDUSTRIES
PROFESSIONALS
CLIENTS
Clients
Large Volume Filers
Small Medium Enterprises
Global
Brand Leaders
STARTUP
Start Up
IP Funding: Federal and Provincial Government Grants and Financing
BLOG
ABOUT
About Us
PCK Patents
Practice Overview
Recognition
Careers
Diversity
Pro Bono Services
PCK Events
CONTACT
MyPCK
European Patent Office (EPO)
Filter by
Categories
Tags
Show all
Article
Confusion
Contract
Copyright
Corporate
Domain Names
Employment
Expungement
Expungement
Grey Marketing
Industrial Designs
Licensing
Obviousness
Opposition
Passing Off
Patent
Patent Infringement
Patent Strategy
PCK News
PM(NOC)
Procedure
Prosecution
Services
Summary
Trade Secrets
Trademark
Use
Validity
Abandonment
Abstract Theorems
Abuse of Process
Accounting of Profits
Advertising
AI Patent Requirements
Alice/Mayo Test
Ambiguity
Andrew Currier
Anticipation
Appeal
Apple
Architecture
Artificial Intelligence
Assignment
Bargain Theory
Biosimilar
Biotech Patents
Branding
Buildings
business
CAFC
Canada
Certificate of Supplementary Protection
Chemical Patent
CIPO
claim
Claim Construction
Class Actions
College of Patent Agents and Trademark Agents
combination drugs
Commercial Success
Common General Knowledge
Confidential Information
Confusion
Contract
Copyright
Copyright Infringement
Costs
Counterfeit
Court of Appeals for the Federal Circuit
COVID-19
Damages
Data Protection
Design Patents
Distinctiveness
Diversity
Divisional Applications
DNA Patents
Domain Names
Dosage Range
Double Patenting
Due Care
E-Commerce
Enablement
Estoppel
European Patent Office (EPO)
Evidence
Expert Evidence
Fair Use
Federal Court
Federal Court of Appeal
File Wrapper Estoppel
Food and Drug Regulations
Fraud
funding
Generic Drugs
Google
Hague Agreement
Indefiniteness
Induced Infringement
Industrial Designs
Injunction
Innovation
Innovative Drugs
Insufficient Disclosure
Intellectual Property
Inter Partes Review
Investors
IP Litigation
IP Strategy
IP Treaty
IPIC
Jurisdiction
Law Firm
Licensing IP
Madrid Protocol
Methods of Medical Treatment
Non-Infringing Alternative
Non-Practicing Entity
Novelty
Obviousness
Official Marks
On-Sale Bar
Overbreadth
Ownership & Inventorship
Passing Off
Patent Act
Patent Agent
Patent Appeal Board
Patent Application
Patent Drafting
Patent Fees
Patent Infringement
Patent Law
Patent Lawyer
Patent Litigation
Patent Prosecution
Patent Rules
Patent Strategy
Patent Term Adjustment
Patent Textbook
Patent Trolls
Patent Validity
Patentability
Patentable Subject Matter
Patents
PCT
Pharmaceutical Patent
Pharmaceutical Pricing
PM(NOC)
PMPRB
Pre-approved list
Prior Art
Prior Disclosure
prior use
Priority
Privilege
Product Specificity
Products
Promise Doctrine
Provisional Patent
Public Domain
Punitive Damages
Quebec
Registered Trademarks
Reinstatement
Remedies
SCOTUS
Sebastian Beck-Watt
Section 45
Selection Patent
Software
Software Copyright
Software Patent
Sound Prediction
Springboard Profits
SRED
Standard of Review
Start-up
Startups
Supreme Court of Canada
Technology
TMOB
Trade Secrets
Trademark
Trademark Agent
Trademark application
Trademark Expungement
Trademark Fees
Trademark Infringement
Trademark Law
Trademark Opposition
Trademark Ownership
Trademark Registration
Trademarks Act
Trademarks Opposition Board
United States
Use
USPTO
Utility
admin
administrator
ashley
Gillian Burrell
PCK
PCK-Reporter
pckip
Wendy Low
November 11, 2024
November 11, 2024
European Patent Office Boards of Appeal Issues Notable Decision on Machine Learning and Patentability
A recent EPO decision on machine learning patents emphasizes the need for detailed technical disclosures, clarifying standards for inventors aiming to secure patent protection for AI innovations.
